2001-03-15T00:00:00
Budget warning follows latest NICE drug approvals The National Institute for Clinical Excellence has approved the use of orlistat for obesity and pioglitazone for type-2 diabetes by the NHS in England and Wales. Orlistat may be prescribed to clinically obese adults who also have another serious illness such as high ...
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud